$0.8132
-0.0267-3.18%
Last update: Nov 6, 6:27 PM
Organogenesis Holdings Inc (ORGO) Stock Price, Quote, News & History
ORGONASDAQ
Organogenesis Holdings (NASDAQ:ORGO) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has...
You can purchase shares of Organogenesis Holdings (NASDAQ:ORGO) through any online brokerage.
Other companies in Organogenesis Holdings’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Organogenesis Holdings has a consensus price target of $6.00.
The stock price for Organogenesis Holdings (NASDAQ: ORGO) is $0.85 last updated November 6, 2026 at 6:27 PM EST.
There are no upcoming dividends for Organogenesis Holdings.
Organogenesis Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Organogenesis Holdings.
Organogenesis Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of...
